Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
- PMID: 33069259
- PMCID: PMC7568829
- DOI: 10.1186/s13048-020-00727-3
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
Abstract
Background: Ovarian clear cell carcinoma (OCCC) is a rare histologic type of ovarian cancer. There is a lack of an efficient prognostic predictive tool for OCCC in clinical work. This study aimed to construct and validate nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with OCCC.
Methods: Data of patients with primary diagnosed OCCC in the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2016 was extracted. Prognostic factors were evaluated with LASSO Cox regression and multivariate Cox regression analysis, which were applied to construct nomograms. The performance of the nomogram models was assessed by the concordance index (C-index), calibration plots, decision curve analysis (DCA) and risk subgroup classification. The Kaplan-Meier curves were plotted to compare survival outcomes between subgroups.
Results: A total of 1541 patients from SEER registries were randomly divided into a training cohort (n = 1079) and a validation cohort (n = 462). Age, laterality, stage, lymph node (LN) dissected, organ metastasis and chemotherapy were independently and significantly associated with OS, while laterality, stage, LN dissected, organ metastasis and chemotherapy were independent risk factors for CSS. Nomograms were developed for the prediction of 3- and 5-year OS and CSS. The C-indexes for OS and CSS were 0.802[95% confidence interval (CI) 0.773-0.831] and 0.802 (0.769-0.835), respectively, in the training cohort, while 0.746 (0.691-0.801) and 0.770 (0.721-0.819), respectively, in the validation cohort. Calibration plots illustrated favorable consistency between the nomogram predicted and actual survival. C-index and DCA curves also indicated better performance of nomogram than the AJCC staging system. Significant differences were observed in the survival curves of different risk subgroups.
Conclusions: We have constructed predictive nomograms and a risk classification system to evaluate the OS and CSS of OCCC patients. They were validated to be of satisfactory predictive value, and could aid in future clinical practice.
Keywords: Cancer-specific survival; Nomogram; Ovarian clear cell carcinoma; Overall survival; Predict.
Conflict of interest statement
The authors declare that they have no competing interest.
Figures





Similar articles
-
Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.Front Oncol. 2022 Nov 9;12:940601. doi: 10.3389/fonc.2022.940601. eCollection 2022. Front Oncol. 2022. PMID: 36439411 Free PMC article.
-
Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.Front Oncol. 2024 Mar 21;14:1370272. doi: 10.3389/fonc.2024.1370272. eCollection 2024. Front Oncol. 2024. PMID: 38577328 Free PMC article.
-
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8. Sci Rep. 2025. PMID: 40000793 Free PMC article.
-
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.J Ovarian Res. 2023 Apr 14;16(1):75. doi: 10.1186/s13048-023-01144-y. J Ovarian Res. 2023. PMID: 37059991 Free PMC article. Clinical Trial.
-
Prognostic nomograms for young breast cancer: A retrospective study based on the SEER and METABRIC databases.Cancer Innov. 2024 Oct 25;3(6):e152. doi: 10.1002/cai2.152. eCollection 2024 Dec. Cancer Innov. 2024. PMID: 39464427 Free PMC article. Review.
Cited by
-
Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy.Int J Gen Med. 2022 Jan 6;15:123-131. doi: 10.2147/IJGM.S337827. eCollection 2022. Int J Gen Med. 2022. PMID: 35023951 Free PMC article.
-
Clinical Prediction Nomograms to Assess Overall Survival and Disease-Specific Survival of Patients with Salivary Gland Adenoid Cystic Carcinoma.Biomed Res Int. 2022 Aug 29;2022:7894523. doi: 10.1155/2022/7894523. eCollection 2022. Biomed Res Int. 2022. PMID: 36072473 Free PMC article.
-
A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center.Front Oncol. 2021 Apr 20;11:670644. doi: 10.3389/fonc.2021.670644. eCollection 2021. Front Oncol. 2021. PMID: 33959514 Free PMC article.
-
Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma.Front Oncol. 2022 Oct 31;12:956380. doi: 10.3389/fonc.2022.956380. eCollection 2022. Front Oncol. 2022. PMID: 36387090 Free PMC article.
-
Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.Front Oncol. 2022 Nov 9;12:940601. doi: 10.3389/fonc.2022.940601. eCollection 2022. Front Oncol. 2022. PMID: 36439411 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources